The Introduction Of Biosimilar Monoclonal Antibodies Into Developed Markets- What Are Payers Concerned About?
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1160
https://www.valueinhealthjournal.com/article/S1098-3015(13)01231-X/fulltext
Title :
The Introduction Of Biosimilar Monoclonal Antibodies Into Developed Markets- What Are Payers Concerned About?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01231-X&doi=10.1016/j.jval.2013.03.1160
First page :
A229
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
737